Already this year Chai Discovery has raised a $130M series B and struck a discovery partnership with Eli Lilly - Co-Founder Jack Dent describes how Chai is using AI to design antibodies
He explains how Chai-2 works, and how it compares to other antibody building / binding AI models.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.